Risk of HIV transmission from patients on antiretroviral therapy: A position statement Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 10, 2014, Pages 673-677

  Albert, Jan ^a,b,c   Berglund, Torsten ^d   Gisslén, Magnus ^c,e   Gröön, Peter ^f   Sönnerborg, Anders ^a,b,c   Tegnell, Anders ^d   Alexandersson, Anders ^g   Berggren, Ingela ^f   Blaxhult, Anders ^h   Brytting, Maria ^c,d   Carlander, Christina ⁱ   Carlson, Johan ^d   Flamholc, Leo ^c,j   Follin, Per ^k   Haggar, Axana ^g   Hansdotter, Frida ^d   Josephson, Filip ^c,l   Karlström, Olle ^b,c,l   Liljeros, Fredrik ^m   Navér, Lars ^a,b,c   Pettersson, Karin ^b,c   Johansson, Veronica Svedhem ^a,b   Svennerholm, Bo ^c,n   Tunbäck, Petra ^c,e   Widgren, Katarina ^d   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Swedish Reference Group for Antiviral Therapy   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f STOCKHOLM COUNTY COUNCIL   (Sweden)

^g NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^h STOCKHOLM SÖDER HOSPITAL   (Sweden)

ⁱ Västmanlands County Hospital   (Sweden)

^j LUND UNIVERSITY   (Sweden)

^k Region Västra GötalandSahlgrenska University Hospital   (Sweden)

^l MEDICAL PRODUCTS AGENCY   (Sweden)

^m STOCKHOLM UNIVERSITY   (Sweden)

ⁿ UNIVERSITY OF GOTHENBURG   (Sweden)

more..

Author keywords

HIV transmission therapy

Indexed keywords

ANTIRETROVIRUS AGENT;

ANAL INTERCOURSE; ANTIVIRAL THERAPY; CHILDBIRTH; COITUS; CONDOM; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; ORAL SEX; PREGNANCY; PUBLIC HEALTH; REVIEW; RISK; SEXUALLY TRANSMITTED DISEASE; SWEDEN; VERTICAL TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PROCEDURES; RISK ASSESSMENT; TRANSMISSION;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, INFECTIOUS; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; RISK ASSESSMENT; SWEDEN;

EID: 84907143424     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2014.926565     Document Type: Review

References (20)

1. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV-infi zierte Menschen ohne andere STD sind unter wirksamer antiretroviraler Therapie sexuell nicht infekti ö s [HIV-infected people free of other STDs are sexually not infectious on effective antiretroviral therapy]. Schweizerische Ä rztezeitung 2008; 89:165-9.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
3. Filder S, Anderson J, Azad Y, Delpech V, Evans C, Fisher M, et al. Position statement on the use of antiretroviral therapy to reduce HIV transmission, January 2013:the British HIV Association (BHIVA) and the Expert Advisory Group on AIDS (EAGA). HIV Medicine 2013; 5:259-62.
4. Eriksson LE. Positivt liv. En internationell kunskaps ö versikt om att unders ö ka livskvalitet och livssituation hos personer som lever med hiv. Sweden:Smittskyddsinstitutet; 2012.
5. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146:87-95.
6. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries:a collaborative analysis of 14 cohort studies. Lancet 2008; 372:293-9.
7. van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals AIDS2010;2415,27-35.
8. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, et al. Projected life expectanc y of people with HIV according to timing of diagnosis. AIDS 2012; 26:335-43.
9. Referensgruppen f ö r Antiviral Terapi (RAV). Antiretroviral behandling av HIV-infektion 2013. Available at:http://folkhalsomyndigheten.se/documents/projektwebbar/rav/rekommendationer/antiretroviral-behandling-hiv-v140210. pdf Lippincott Williams:Wilkins. (accessed).
10. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretrovi-ral therapy:systematic review and meta-analysis. AIDS 2009; 23:1397-404.
11. Loutfy M, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One 2013; 8:e55747.
12. WHO and US NIH Working Group Meeting on Treatment for HIV Prevention among MSM. What additional evidence is required? Geneva, 26-27 October 2011.
13. Sturmer M, Doerr HW, Berger A, Gute P. Is transmission of HIV-1 in non-viraemic serodiscordant couples possible? Antivir Ther 2008; 13:729-32.
14. Politch JA, Mayer KH, Welles SL, O'Brien WX, Xu C, Bowman FP, et al. Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS 2012; 26:1535-43.
15. Lambert-Niclot S, Tubiana R, Beaudoux C, Lefebvre G, Caby F, Bonmarchand M, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetec-table HIV-1 RNA in blood plasma on a 2002-2011 survey. AIDS 2012; 26:971-5.
16. Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba AD. Antiviral agents and HIV prevention:controversies, conflicts, and consensus. AIDS 2012; 26:1585-98.
17. Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users:prospective cohort study. BMJ 2009; 338:b1649.
18. Kirk G, Galai N, Astemborski J, Linas B, Celentano D, Mehta S, et al. Decline in community viral load strongly associated with declining HIV incidence among IDU. Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections, 27 February-2 March 2011, Boston, MA, USA; 2011.
19. Wood E, Milloy MJ, Montaner JS. HIV treatment as prevention among injection drug users. Curr Opin HIV AIDS 2012; 7:151-6.
20. Referensgruppen f ö r Antiviral Terapi (RAV). Profylax och behandling vid graviditet hos HIV-1 infekterade kvinnor, 2013. Available at:http://folkhalsomyndigheten.se/documents/projektwebbar/rav/rekommendationer/profylax-behandling-graviditet-hiv1-infekterade-kvinnor.pdf Lippincott Williams:Wilkins. (accessed).